Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Michael J. Pacini

Michael J. Pacini

Clinical Assistant Professor, Pharmacy Practice



Chicago, IL, United States

Related Sites:

Teaching and Supervision Heading link

Spec Project in Pharm Pract (PMPR 390), 1/9/2023 – 4/28/2023
Drug Delivery Systems Design and Calculations Competency (PHAR 434), 10/24/2019 – Present
Dosage Form Design (PHAR 324), 2016 – Present
Advanced Specialty – APPE (PMPR 388), 1/14/2013 – 5/3/2013
Advanced Specialty – APPE (PMPR 388), 8/27/2012 – 12/7/2012
Oncology (PHAR 408), 2003 – 2007
Recitation Facilitator Oncology (PHAR 408), 2000 – 2007
Recitation Facilitator – Experiential (PHAR 354), 2000 – Present
Hypertension and Diabetes (PMPR 353), 1999 – 2005

Selected Grants

Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (the ATTRACT Trial) INDUSTRY FUNDS, Washington University in St. Louis., 5/4/2012 - 3/31/2015, Obligated Amount: $45000; Anticipated Amount: $45000

Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (the ATTRACT Trial) NON-INDUSTRY FUNDS, Washington University in St. Louis., 7/1/2011 - 3/31/2013, Obligated Amount: $35000; Anticipated Amount: $35000

Selected Publications

Molokie, R, Lavelle, D, Gowhari, M, Pacini, M, Krauz, L, Hassan, J, Ibanez, V, Ruiz, MA, Ng, KP, Woost, P, Radivoyevitch, T, Pacelli, D, Fada, S, Rump, M, Hsieh, M, Tisdale, JF, Jacobberger, J, Phelps, M, Engel, JD, Saraf, S, Hsu, LL, Gordeuk, V, DeSimone, J, Saunthararajah, Y. (2017). Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. PLoS Medicine, 14, (9). doi:10.1371/journal.pmed.1002382.

Lulla, RR, Goldman, S, Yamada, T, Beattie, CW, Bressler, L, Pacini, M, Pollack, IF, Fisher, PG, Packer, RJ, Dunkel, IJ, Dhall, G, Wu, S, Onar, A, Boyett, JM, Fouladi, M. (2016). Phase i trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study. Neuro-Oncology, 18, (9), 1319-1325. doi:10.1093/neuonc/now047.

Beri, R, Rosen, FR, Pacini, MJ, Desai, SR. (2004). Severe Dermatologic Reactions at Multiple Sites after Paclitaxel Administration. Annals of Pharmacotherapy, 38, (2), 238-241. doi:10.1345/aph.1D206.


PharmD, University of Illinois at Chicago, United States, 1991

Licensures and Certifications

Board Certified Oncology Pharmacist, Board Certified Oncology Pharmacist, 12/2000 - 12/2028

Selected Presentations

Chan, David, Villarell-Flores, M, Pacini, M. (2016 October 18). Development of Digital Resources to Enhance Clinical Research Safety and Efficiency. University of Illinois Hospital and Health Sciences System 6th Annual Patient Safety Fair. Chicago, USA.